News & Research

Review major news and articles.
Stasys Medical receives NSF SBIR Phase IIB & NIH SBIR Phase I in investment round, and platelet forces shown to be a clinical predictor for blood transfusion in the ER
Read the paper
Stasys Medical receives NSF SBIR Phase II grant for development of a device to rapidly identify the source of uncontrolled bleeding in major trauma

SEATTLE, Wash. – March, 2015 – Stasys Medical Corporation has received a National Science Foundation Small Business Innovation Research Phase IIb grant (NSF SBIR PIIb), and a National Institute of health Small Business Innovation Research grant (NIH SBIR PI) totaling $725K. The company will use these grants to conduct product development and research to understand the ways that Stasys’ technology can be utilized to help manage bleeding and coagulation in surgical, ER, and personalized medicine applications. This is the latest grant award in addition to receiving a NSF SBIR PII award, and investment led by Table10 group bringing the recent investment into Stasys to $2.1M.